⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CURX News
Curanex Pharmaceuticals Inc Common Stock
Curanex Highlights Patient Case Study Supporting Potential of Phyto-N in Cancer Cachexia and Advanced Cancer Supportive Care
globenewswire.com
CURX
Form 8-K
sec.gov
CURX
Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company
globenewswire.com
CURX
Curanex Provides Business Update in Connection with 2025 Annual Report as Phyto-N Advances Toward Planned IND Submission
globenewswire.com
CURX
Curanex Achieves Key Preclinical Milestone with Favorable Toxicology Profile at Maximum Dose, Advancing Toward IND Submission
globenewswire.com
CURX
Curanex Expands Scientific Advisory Board With Two Distinguished Researchers
globenewswire.com
CURX
Curanex Appoints Two Veteran Industry Leaders to Scientific Advisory Board
globenewswire.com
CURX
Form 8-K
sec.gov
CURX
Curanex Forms World Class Scientific Advisory Board
globenewswire.com
CURX
Obesity Care Week 2026 Calls for Action to Improve Access to Obesity Care
prnewswire.com
LLY
GNE
REGN
AMGN
BSX
CURX
NVO
ZETA